We help eligible patients access Januvia (sitagliptin) for the management of type 2 diabetes for as little as $69.95 per month through manufacturer Patient Assistance Programs.
The Januvia Prescription Assistance Program is a manufacturer-sponsored initiative that provides Januvia at no medication cost to qualifying patients, including certain insured and Medicare Part D patients. A savings card reduces costs to as little as $5 per prescription for commercially insured patients.
AffordMyPrescriptions ensures effective diabetes management is accessible. For a flat $69.95 per month, our Patient Advocates identify the most affordable pathway — brand PAP, $5 copay card, Medicare negotiated pricing, or generic sitagliptin.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$110 | Save ~$40/mo |
| CVS Pharmacy | ~$109 | Save ~$39/mo |
| Walmart | ~$109 | Save ~$39/mo |
| Costco | ~$109 | Save ~$39/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Patient Assistance Program is free to apply and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management. Our $69.95/month covers full advocacy: applications, doctor coordination,
documentation, refill management, and re-enrollment — so you focus on your health, not paperwork.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution:
Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements can vary, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation.
Januvia (sitagliptin) is a once-daily prescription oral tablet for adults with type 2 diabetes. It works by enhancing the body’s natural incretin system to lower blood sugar after meals. Available in 25 mg, 50 mg, and 100 mg strengths (100 mg is standard). Typically used alongside diet, exercise, and metformin.
How It Works:
Januvia blocks the DPP-4 enzyme that destroys natural incretins. With DPP-4 blocked, incretins remain active longer — signaling the pancreas to release more insulin when blood sugar is high and telling the liver to produce less sugar. This effect is glucose-dependent, meaning low hypoglycemia risk.
Form and Use:
One tablet once daily, with or without food, at any convenient time.
Generic/Biosimilar Availability:
Generic sitagliptin is available at approximately $59–$109 with coupons. Key patent expires November 2026, expected to bring broader generic competition. For Medicare patients, IRA negotiated price is ~$113/month effective January 2026.
Warnings:
Rare risk of pancreatitis. Report severe abdominal pain to your doctor immediately. Do not stop diabetes medication without medical guidance.
Brand-name Humira costs approximately $6,900–$10,000+ per month. With GoodRx coupons, the best price is approximately $6,380. Biosimilar alternatives range from $550–$1,320 with coupons. Through AffordMyPrescriptions, qualifying patients receive Humira at no medication cost for $69.95/month.
Yes. Generic sitagliptin is available at ~$59–$109 with coupons. Key patent expires November 2026, expected to bring more generics and lower prices.
Januvia has a low risk of hypoglycemia when used alone or with metformin because it only stimulates
insulin when blood sugar is elevated. Risk increases if combined with a sulfonylurea or insulin.
Yes. The negotiated Medicare price dropped from ~$527 to ~$113/month effective January 2026, with a $2,100 annual out-of-pocket cap.
Both work through the incretin system but differently. Januvia is an oral tablet preserving natural incretins. GLP-1 medications like Ozempic are injections that directly mimic incretins at higher levels, producing stronger effects and significant weight loss.
If you are struggling with the high cost of Januvia, our team may be able to help you access
assistance programs designed to make medications more affordable. Check your eligibilitytoday and take the first step toward reducing your prescription costs.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.